Drug Trial Radar · NCT05637606
HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients Undergoing Major Abdominal Surgery
Last checked: Nov 20, 2026Latest source record: Jun 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
636
Actual
Start
Mar 6, 2023
Primary completion
May 21, 2025
Study completion May 21, 2025
Sponsor
- Lead sponsor
- Humanitas Clinical and Research CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
- First posted
- Dec 5, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter randomized controlled trial comparing two strategies of mean arterial blood pressure management (MAP ≥ 80mmHg vs MAP ≥ 65 mmHg) in high-risk surgical patients undergoing elective laparotomic/laparoscopic surgery.
Conditions
- Blood Pressure
- Complication,Postoperative
- Intraoperative Hypotension
Interventions
EphedrineDrug
In both the group, the target MAP can be maintained by means of bolus of ephedrine (2.5 mg). The maximal dose for the ephedrine allowed is 25 mg (10 boluses of 2.5 mg), after this threshold a continuous infusion of norepinephrine will be started
NorepinephrineDrug
In both the group, the target MAP can be maintained by means of bolus of ephedrine (2.5 mg) or Etilefrine (1 mg). The continuous infusion of norepinephrine, as decided by the attending anesthetist, may be started at any point of the intraoperative period. The starting dose of norepinephrine is the lowest needed to reach the predefined MAP target.
Etilefrine Hydrochloride bolusDrug
The maximal dose for the etilefrine allowed is 10 mg (10 boluses of 1 mg), after this threshold a continuous infusion of norepinephrine will be started
Use of pulse pressure and stroke volume variation (PPV and SVV); use of Mini Fluid Challenge (mini_FC)Diagnostic test
PPV, SVV and mini\_FC will guide fluid bolus administration during an episode of intraoperative hypotension, following two predefined algorithms for laparotomic/non laparotomic surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite endpoint of postoperative mortality and at least one major organ dysfunction (see description in the secondary outcomes).Time frame: up to 30 days after operation
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Azienda Ospedaliero - Universitaria SS. Antonio e Biagio e Cesare Arrigo
Alessandria, Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
Istituto Nazionale dei Tumori
Milan, Italy
Ospedale Antonio Cardarelli
Naples, Italy
Azienda sanitaria Friuli Occidentale (AsFO]
Pordenone, Italy
Ospedale Santo Stefano
Prato, Italy
Ospedale S. Anna di Castelnovo ne' Monti
Reggio Emilia, Italy
Sant'Eugenio ASL Roma 2:
Roma, Italy
Azienda Ospedaliero Universitaria di Sassari
Sassari, Italy
Ospedale Molinette
Torino, Italy
Ospedale Santa Chiara di Trento
Trento, Italy
Ospedali Riuniti Foggia- Università di Foggia
Foggia, Apulia, Italy
Department of Anesthesia and Intensive Care, University Hospital of Modena
Modena, Emilia-Romagna, Italy
Policlinico A. Gemelli
Rome, Lazio, Italy
Humanitas Research Hospital
Rozzano, MILANO, Italy
Fondazione Istituto San Raffaele G. Giglio
Cefalù, Sicily, Italy
Careggi University Hospital
Florence, Tuscany, Italy
Unit of Anesthesiology and Intensive Care B, Department of Surgery, Dentistry, Gynecology and Pediatrics, AOUI-University Hospital Integrated Trust of Verona
Verona, Veneto, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.